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Abstract 
Protein phosphorylation and de-phosphorylation is one of the most common signalling 
pathways within cells, it is involved in regulating cellular processes, mediating enzyme 
inhibition, protein-protein recognition and protein degradation. Compared with normal 
proteomics, phosphoproteomics poses some additional challenges requiring more initial 
separation and additional sensitivity to detect and quantify potentially ultra-low abundance 
species. In this work, the selective detection of phosphopeptides is described based on the 
incorporation of a metal tag, gallium–N,N-biscarboxymethyl lysine (Ga-LysNTA), in 
solution before separation and detection by liquid chromatography coupled to inductively 
coupled plasma mass spectrometry (LC-ICP-MS). Experimental and theoretical 
characterisation of the resulting Ga-phosphopeptide complex is presented based on linear ion 
trap electrospray ionisation mass spectrometry (ESI-MS), Fourier transform mass 
spectrometry (FT-MS) and molecular modelling data.  Linear ion trap electrospray ionisation 
mass spectrometry (ESI-MS) was employed to study the interaction of the gallium tag with 
platelet derived growth factor beta receptor (β-PDGF), a small phosphopeptide. In addition 
high resolution Fourier transform mass spectrometry (FT-MS) was used for accurate mass 
determination and multistage tandem mass spectrometry of the gallium-β-PDGF complex 
identified the fragmentation pathway.  Finally, molecular modelling was used to investigate 
the energetically favoured structures of both the Ga-LysNTA material and the β-PDGF-Ga-
LysNTA complex.  
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Introduction 
Protein phosphorylation is an important post-translational modification and plays an 
important role in the regulation of many systems within organisms.  Irregular protein 
phosphorylation can result in diseases such as chronic myelomonocytic leukaemia and 
papillary renal cancer.[1] The characterisation of phosphorylation sites has been widely 
investigated by the use of tandem mass spectroscopy.[2-11] A typical phosphoproteome 
work-flow involves the purification of the protein of interest by gel electrophoresis or 
reversed phase chromatography, trypticdigestion, enrichment of phosphopeptides followed by 
analysis using liquid chromatography coupled to tandem mass spectrometry. Phosphopeptide 
identification by triple quadrupole mass spectrometry is achieved by two methods; neutral 
loss scans that identify phosphopeptides from the loss of H3PO4 or HPO3 on collisional 
activation from phosphorylated serine and threonine residues or parent ion scans for the 
common product ions H2PO4- or PO3- .[12-14] 
It is often necessary to enrich phosphopeptides following digestion of the target protein, due 
to their low concentrations and poor ionisation efficiencies in positive mode mass 
spectrometry.[15-29] Many different analytical techniques have been developed to 
specifically enrich phosphopeptides including Immobilised Metal Affinity Chromatography 
(IMAC), utilizing iron, gallium, and more recently titanium and zirconium. [15, 18, 29-47] 
The efficiency of each of these metals in selectively binding phosphopeptides has been 
extensively investigated many times with varying success. This has been attributed to the 
non-specific binding of the acidic amino acid residues asparagine and glutamine to the metal 
ions, the binding of hydrophobic residues to the gel bed and the elution of multiply 
phosphorylated peptides and impurities in the metal oxide material. [48, 49] Research 
suggests that selectivity can also be dependent on the combination of resin bed and metal ion, 
with several studies showing that nitrilotriacetic acid (NTA) combined with Fe3+ gave higher 
specificity for phosphopeptides than iminodiacetic acid (IDA) with Fe3+ [50, 51] however, 
when Ga3+ was used the reverse was found to be true and IDA gave better specificity than 
NTA, [52] although Ga3+ was found to have better selectivity overall. [52-55] Selectivity can 
also be improved by blocking acidic amino acid residues by methyl-esterification, [56] 
however there were two problems reported with this approach these being incomplete 
esterification [57] and increased complexity due to side reactions. [39] Additionally, 
selectivity for mono- and multiply-phosphorylated peptides is dependent on both the metal 
ion and the pH of the loading and elution buffers.  Reports have shown that Ti2+ and Fe3+ 
have a higher selectivity for mono-phosphorylated peptides. [58, 59] Peptides containing 
phosphorylated serine and threonine residues can be enriched and modified by methods based 
on Isotope Coded Affinity Tags, [10, 60] in which the phosphate group is eliminated by base 
hydrolysis and a biotin or mercaptoethanol group is introduced by Michael addition, then 
selectively detected by capture/elution with streptavidin or with sulphur specific antibodies. 
[12] Several metals have been used as tags for phosphopeptide detection and quantitation 
especially chelating agents containing zinc and manganese di-coordinate centres. [61-65]   
The advantage of using these metal tags is that the metal chelate binds to the phosphate group 
regardless of which amino acid residue is phosphorylated. [63] Precipitation of 
phosphopeptides and phosphoproteins by metal ions including calcium [66] and trivalent 
europium, terbium and erbium [67] have also been used for enrichment from complex 
samples such as milk and egg whites.  Homogeneous metal based assays have been 
previously reported, including polymer-based methods [68] in which titanium dioxide was 
used to identify phosphopeptides in complex samples and antibody metal labelled assays [69] 
which have utilised mass cytometry and single cell analysis to provide system-wide views of 
immune signalling.  
Blacken et al. [12, 59] reported the use of post separation column tagging of phosphopeptides 
with N,N-biscarboxymethyl-lysine ligand (Ga-LysNTA, C10H16N2O6Ga) prior to analysis by 
tandem mass spectrometry. We hypothesized that this tag could be used homogeneously in 
solution to selectively tag phosphopeptides followed by separation and analysis employing 
the very high selectivity and sensitivity of ICP-MS to quantify the Ga.  For this approach to 
become a viable analytical method the requirement is for a stable stoichiometry between the 
Ga and the phosphopeptide (notionally a 1:1 complex) and for high selectivity to the 
phosphate group. Binding to the phosphate group was reported to be independent of the 
amino acid to which the phosphate group is bound. [12, 59]   Due to the potential complexity 
of working with mixtures of phosphopeptides derived from tryptic digests, a model system 
was chosen that would lend itself to careful analysis by mass spectrometry supported by 
molecular modelling. Conventional structural analysis techniques such as XRD or NMR were 
not considered here because in the analytical context this method has to work at the nmol 
level if it is to be useful and therefore we have restricted the experimental work to techniques 
that can function at that level. 
 
The feasibility of using this homogeneous metal affinity tagging ‘HMAT’ of 
phosphopeptides in solution was investigated.  HPLC coupled to high resolution, sector-field 
ICP-MS was used for the separation of the resultant complexes and detection of both 69Ga 
and 31P signals. Elemental mass spectrometry is preferred over other techniques as it offers 
lower detection limits, a larger dynamic range, a response that is to a first approximation 
independent of molecular form, and potentially more accurate quantification at low 
concentrations by isotope dilution analysis. Linear ion trap electrospray ionisation mass 
spectrometry (ESI-MS) was employed to study the interaction of the gallium tag with platelet 
derived growth factor beta-receptor (β-PDGF) which is a cell surface receptor that is 
important in the regulation of cell proliferation, growth and development and is linked to 
many disease states including cancer. In addition high resolution Fourier transform mass 
spectrometry (FT-MS) was used for accurate mass determination and multistage tandem mass 
spectrometry of the gallium-β-PDGF complex formation and determination of the fragment 
pathway.  Finally, molecular modelling was used to complement the experimental results and 
to obtain more detailed structural and thermodynamic data for the complexes formed.  
 
Materials and methods 
Instrumentation 
Electrospray-MS. An LTQ linear ion trap mass spectrometer (Thermo Scientific, San Jose, 
USA) and a high resolution Q-Exactive Fourier transform mass spectrometer (Thermo 
Scientific, San Jose, USA) were used in this study for mass spectrometric determinations. 
The LTQ-MS was equipped with an electrospray ionisation (ESI) source operated in positive 
mode at 5.5 kV and 280 ºC for the capillary temperature.  Nitrogen was used as the 
nebulising gas with sheath, auxiliary and sweep gas flows set at 50, 10, and 10 arbitrary units, 
respectively. The Q-Exactive was equipped with a Tri Versa NanoMate ESI chip nanospray 
(Advion, New York, USA). Both instruments were calibrated using Ultramark® 1621, 
caffeine and Met-Arg-Phe-Ala (MFRA) in accordance with the manufacturer’s 
recommendations. 
ICP-MS. Thermo Element 2 XR (Thermo Scientific, Hemel Hempstead, UK), with operating 
conditions as follows, an operating power of 1.25 kW,  plasma gas flow of 15.50 L min-1, 
nebuliser gas flow of 1.18 L min-1 and an auxiliary flow of 0.85 L min-1.  The instrument was 
optimised with a standard solution containing 1 ng mL-1 of In, Li and Pb. For LC-ICP-MS 
analysis, the column outlet was directly connected via a 0.005’’ peek tube to a 
poly(fluoroalkoxy), (PFA) LC nebuliser (Elemental Scientific, Omaha, USA). A cyclonic 
spray chamber (Elemental Scientific, Omaha, USA) was used throughout all analyses.  
Reversed-Phase HPLC system. Reversed-phase separations were carried out using a Thermo 
Surveyor MS Pump Plus (San Jose, Ca, USA) and sample injections were performed by a 
Thermo Micro AS (San Jose, Ca, USA). The HPLC column used for the separation was a 
Supelco Ascentis Express Peptide C18 column (150 x 2.1mm, 2.7 µm).  
 
 Materials  
Nα,Nα-Bis(carboxymethyl)-L-lysine hydrate (LysNTA,C10H18N2O6 .xH2O > 97%), Gallium 
(III) chloride (anhydrous, 99.99% trace metals free), ammonium acetate (99.99% trace metals 
free) and acetic acid were purchased from Sigma Aldrich (Dorset, England). Trypsin Gold 
(mass spectrometry grade) was purchased from Promega (Southampton, UK). Methanol 
(HPLC grade) was sourced from Thermo Fisher (Loughborough, UK). Water was purified to 
18 MΩ using an Elix and Element System (Millipore, Billerica, Massachusetts, USA).  
 
Sample Preparation and Procedures 
Formation of β-PDGF-Ga-LysNTA: LysNTA (5.2 mg), Ga2Cl6(4.7 mg) and β-PDGF (0.5 
mg) were dissolved in 5 mL of 50:50 (v/v) methanol:water solution to give a final 
concentration of 0.1 mg mL-1 of β-PDGF-Ga-LysNTA with a10 fold excess of LysNTA and 
Ga2Cl6.  For ESI-MSn analysis further dilution was not necessary, for LC-ICP-MS analysis 
the sample was diluted in 50:50 (v/v) methanol:water solution to a concentration of 10 µg 
mL-1 of β-PDGF-Ga-LysNTAassuming a 100% tagging efficiency.  
 
Confirmation of β-PDGF-Ga-LysNTA formation by ESI-MSn.  To optimise signal intensity 
for the ions of interest, the LTQ Ion Max auto-tune optimisation was performed to set the 
values for the lens, quadrupole and octapole voltages.  Helium gas was used as the collision 
gas for collision-induced dissociation (CID) with the ion-trap held at a pressure of 
approximately 10-3 Torr.  Fragmentation experiments were conducted by selecting the ion of 
interest with an isolation width of 8 Daltons, collisional activation was applied by setting the 
activation amplitude (the amplitude of the radiofrequency (RF)) at 15 – 25 % of the 
maximum voltage available (determined empirically) and an activation Q set at 0.25 units. 
Sample solutions were infused at a flow rate of 10 µL min-1 through an electrospray probe 
using nitrogen as the nebulising gas, with sheath gas flows set to 10 arbitrary units.  
 
Confirmation of β-PDGF-Ga-LysNTA formation by LC-ICP-MS.  To confirm successful 
binding of Ga-LysNTA to β-PDGF, HPLC separation coupled to ICP-MS detection was 
performed employing a linear gradient over 15 mins from 5 % aqueous (Eluent A: 100 % 
H2O with 0.05 % acetic acid) to 70 % organic (Eluent B: 100 % CH3OH with 0.05 % acetic 
acid) at a total flow rate of 100 µL min-1. The column was allowed to re-equilibrate for 5 
minutes between injections.  Both mobile phases were spiked with 500 ppt of Mo to act as an 
internal standard to monitor changes in sensitivity due to the increase in organic solvent.  The 
sample injection volume was 5 µL, which gave 50 ng of β-PDGF-Ga-LysNTA (34 ng of β-
PDGF) on column.  The column was heated to 30 oC for the length of the run. To decrease 
the concentration of organic solvent in the plasma, an additional flow of 700 µl min-1 of H2O 
was added post-column. For the ICP-MS analysis; the power was set to 1.25 kW, nebuliser, 
auxiliary and plasma gases to 1.18, 0.85 and 15.50 L min-1 respectively and operated in 
‘speed mode’ in medium resolution. 
 
Computational Methods 
All calculations were performed with Gaussian 09. [70] Initially structures were optimized 
without symmetry constraints by means of Hartree–Fock (HF) calculations using the STO3G 
basis set.  These initial optimisations were then used as starting geometries for higher level 
calculations employing density functional theory (DFT) at the B3LYP level, [71] in 
conjunction with the electron core potential (ECP) double-zeta LANL2DZ basis set. [72, 73]  
All critical points were characterized by harmonic frequency calculations and were shown to 
be at minima.  Total energies, zero point energies, thermal corrections and entropies are given 
in supplementary material.  The relative computational tractability of this theoretical method 
makes it suitable for calculations of systems containing relatively large numbers of heavy 
atoms such as those under study here.  Much more importantly however are the results of 
DFT calculations in systems involving transition metals, which are in many cases in better 
agreement with experimental data than those obtained from Hartree–Fock (HF) calculations. 
[74] A two-layer ONIOM (Quantum Mechanical (QM):Semi-Empirical (SE)) calculation at 
the (B3LYP/LANL2DZ:PM6) level was conducted on the lowest energy species found for 
the β-PDGF-Ga-LysNTA complex.  In a two-layered calculation the complex under study is 
separated into model and real regions.  The real region contains all the atoms of the complex 
and is thus calculated only at the lower level being the PM6 semi-empirical method.  The 
PM6 method was chosen here as it has been shown to have suitable parameterization for 
biochemical systems and the capabilities of carrying out calculations on molecules containing 
transition metals such as the complex investigated here. [75] The model region on the other 
hand contains the reactive centre and any other part of the system that is of particular interest.  
Both higher level of theory employing the B3LYP/LANL2DZ method and lower level 
calculations using PM6 were carried out for the model region.  The total energy of this 
system was obtained from these three independent calculations: 
 ܧைேூைெ ൌ ܧ௥௘௔௟,ௌா ൅ ܧ௠௢ௗ௘௟,ொெ െ	ܧ௠௢ௗ௘௟,ௌா										ሺ݁ݍ. 1ሻ	 
 
When dividing the complex into the real and model regions care was exercised not to cut 
through multiple covalent bonds or aromatic systems.  However, because there are single 
covalently bonded interactions between the two regions, hydrogen link atoms were chosen to 
saturate the open valence created.    
 
Results and Discussion 
 
Evidence for Ga-LysNTA tag formation  
Evidence for the formation of Ga-LysNTA can be observed in the experimental data shown 
in Panel A of Figure 1. This experimental isotopic pattern compares very favourably with the 
theoretical isotopic pattern of Ga-LysNTA shown in Panel B of Figure 1. The formation of 
Ga-LysNTA was further confirmed by means of accurate mass FT-MS where the average 
mass deviation was only 0.08 ppm (See Table 1) (as calculated according to equation 2 
shown below) for the observed isotopic peaks that make up the experimental pattern for Ga-
LysNTA. 
݌݌݉	 ൌ 	 ൬ܯ௘௫௣ 	െ	ܯ௖௔௟௖ܯ௖௔௟௖ ൰ 	ൈ 1ܧ
଺					ሺ݁ݍ. 2ሻ 
 
Calculations on the Ga-LysNTA+ species were initially performed at HF/STO3G, the lowest 
five energy species from these calculations were re-optimised at the B3LYP/LANL2DZ level 
of theory.  The lowest energy conformation calculated for this species is structure 1A as 
shown in Figure 2.  In this structure the gallium metal is tetra-coordinated, binding to three 
carbonyl oxygen atoms as well as to the backbone nitrogen of the LysNTA substrate.  This 
binding arrangement, while serving to dissipate the large positive charge on the metal centre, 
also results in the formation of three distinct five membered heterocyclic rings with the 
gallium metal being at their intersection.  Highlighted in Structure 1A is a strong hydrogen 
bond (1.595 Å as calculated at B3LYP/LANL2DZ) where the hydrogen atom formally 
resides on the terminal amino nitrogen and is shared with the closest carbonyl oxygen atom.  
This hydrogen bonding results in the formation of a pseudo-nine membered ring along the 
LysNTA backbone.  The large number of rings that result due to this conformational 
geometry is responsible for one of the lowest entropy terms calculated out of all 
conformations considered for the Ga-LysNTA species as listed in supplementary materials 
(see Table S1).  The next lowest energy species on this surface is Structure 1B being 10.3 
kcal mol-1 higher in free energy, in this structure the gallium centre is also tetra-coordinated 
and is also at the intersection of three distinct heterocyclic rings.  The coordinating sites to 
the gallium metal in Structure 1B are the terminal amino nitrogen, the backbone nitrogen as 
well as two of the carbonyl oxygen atoms of the LysNTA substrate.  This geometric 
arrangement results in the formation of two of the smaller five membered heterocyclic rings 
and one larger eight membered heterocyclic ring.  Structure 1C is calculated to be 37.6 kcal 
mol-1 higher in free energy on the potential energy surface relative to Structure 1A.  This 
higher energy species shows a similar gallium metal coordination as that of Structure 1A 
being tetra-coordinated and binding to three carbonyl oxygen atoms as well as to the 
backbone nitrogen of the LysNTA substrate.  The lack of formal coordination and the 
absence of any hydrogen bonding at the amino nitrogen in Structure 1C allows for a much 
more extended backbone arrangement relative to that of Structure 1A.  This is evident in the 
larger entropy term listed in supplementary materials for Structure 1C.  Structure 1D is nearly 
identical to Structure 1C with the former having a gallium hydroxyl oxygen coordination 
substituting for a stronger coordination of the metal to one of carbonyl oxygen atoms of the 
LysNTA substrate in the latter.  This difference in coordination makes Structure 1D seven 
kcal mol-1 higher in free energy relative to Structure 1C.  The lowest energy structure 
calculated on this surface is Structure 1E, where the gallium metal is tri-coordinated, the 
metal centre binding to two carbonyl oxygen atoms and the backbone nitrogen of the 
LysNTA substrate.  The gallium-carbonyl oxygen bonds in Structure 1E are calculated to be 
1.758 and 1.754 Å which are much shorter and thus stronger than those found in Structure 1A 
being 1.787, 1.794 and 1.841 Å respectively.  Structure 1E also features a strong hydrogen 
bond (1.493 Å as calculated at B3LYP/LANL2DZ) between a hydrogen atom which formally 
resides on the terminal amino nitrogen and a carbonyl oxygen atom.  This hydrogen bonding 
helps to stabilise Structure 1E, however, the lower coordination number of gallium in this 
structure makes it nearly 60 kcal mol-1 higher in energy relative to Structure 1A. The 
remaining structures 1F, 1G and 1H shown in Figure 2 were the highest energy species 
calculated at HF/STO3G being 48.8, 57.0 and 127.3 kcal mol-1 higher in free energy 
respectively relative to Structure 1A and were thus not considered at the higher level of 
theory.    
 
The presence of a water adduct to Ga-LysNTA was identified and confirmed by comparison 
of the experimental signal with the theoretical isotope pattern model and was found to be in 
excellent agreement with an average mass accuracy of 0.08 ppm (see Figure 3 and Table 1). 
An interesting cluster was observed at m/z 361-370, which is proposed to be due to the 
signals of LystNTAGa•CH3OH and Ga-LysNTA•2H2O adducts (see Figure 4). Closer 
inspection of this cluster and matching to modelled theoretical isotope patterns indicated that 
it consisted of a 2:1 ratio of [Ga-LysNTA•MeOH]+:[Ga-LysNTA•2H2O]+. This suggests that 
the two acidic carbonyl groups have lost a hydrogen atom in order to form two ionic bonds to 
the gallium cation in the Ga-LysNTA complex; therefore the Ga-LysNTA is unlikely to 
accept lone pairs from remaining water molecules in the gas phase. 
 
 
Evidence for β-PDGF Ga-LysNTA complex formation  
The complexation of Ga-LysNTA with the phosphopeptide PDGF β-receptor, which has a 
primary structure of H-pTyr-Val-Pro-Met-Leu-OH, to form the Ga-LysNTA-β-PDGF adduct 
at m/z of 1030.3, was confirmed by comparison with the theoretical isotope pattern (see 
Figure 5) and by accurate mass FT-MS with an average mass accuracy of 4 ppm (see Table 
1). The Ga-LysNTA and β-PDGF reactants are also visible in the mass spectrum (see Figure 
5). Several other species which were observed in the mass spectrum were identified and 
annotated in Figure 5. To further confirm the formation of Ga-LysNTA-β-PDGF, the 
resulting entire isotopic pattern was selected at an isolation width of 8 Da and fragmented at 
collision energy of 15 eV, resulting in the MS/MS spectrum shown in Figure 6. 
Fragmentation of the complex resulted in daughter ions representing β-PDGF and the cluster 
at m/z 361-370 as described above.  
 
Complementary evidence for the formation of Ga-LysNTA-β-PDGF was obtained by means 
of HPLC-ICP-MS, using the conditions outlined in the methods section.  The chromatogram 
obtained shows a single peak in the 31P signal trace at a retention time of 3.89 mins which 
corresponded to an exact retention time match to that of the complexed 69Ga signal peak, 
confirming the formation of Ga-LysNTA-β-PDGF, see Figure 7. The earlier eluting 69Ga 
peak at 3.13 mins, was most likely due to unbound Ga-LysNTA as confirmed from a separate 
LC-ICP-MS run of Ga-LysNTA in the absence of β-PDGF (data not shown). The sample 
introduction system was not optimised for sensitivity and so an 8 fold post column dilution 
was employed to reduce plasma instability due to the high concentration of methanol in the 
mobile phase. The detection limit for Ga (calculated from three times the standard error in the 
curve) was 0.5 ng ml-1 which for a 10 l injection equates to 5 pg Ga or ~50 pg of PDGF. 
The 98Mo signal remained constant throughout the chromatographic run as would be expected 
given that the gradient eluent was diluted 8 fold post column. 
 
Computational modelling of this complex between the Ga-LysNTA species and the 
phosphopeptide PDGF β-receptor was performed in order to gain insight into the structure.  
Six conformations of this complex were calculated at HF/STO3G (see the results listed in 
Table S1).  Due to the size of the Ga-LysNTA-β-PDGF system it was computationally 
prohibitive to employ higher levels of theory for their calculations, however, as observed 
before for the Ga-LysNTA species calculated in this work, the relative free energy ordering 
of the conformers calculated did not change from the lower HF method to the higher level of 
theory employed here.  The most favoured of the six structures energetically is Structure 2A 
as shown in Figure 8 in which the gallium metal is a penta-coordinate centre.  In this structure 
the gallium centre binds to two carbonyl oxygen atoms of the LysNTA substrate which does 
not exhibit any formal binding or hydrogen bonding at its terminal amino nitrogen resulting 
in an extended open arrangement for backbone of the LysNTA substrate in the formed 
complex.  Structure 2A also shows the gallium centre binding to the two carbonyl oxygen 
atoms of the valine and methionine residues of the phosphopeptide PDGF β-receptor while 
the last coordinating site to the gallium metal is one of the oxygen atoms of the phosphate 
moiety which replaces the hydrogen of the hydroxyl group of the tyrosine residue.  This 
observation is extremely important as it throws some light on why the literature offers diverse 
and sometimes contradictory information about the efficiency and selectivity of IMAC (and 
in this case the related HMAT) techniques.  Whilst the Ga certainly does target the phosphate 
group, it only uses one of the phosphate oxygens with the other analyte derived coordination 
sites being provided by electron donating centres on the amino acid residues of the peptide. 
Structure 2B (not shown, see Table S1) is the lowest energy conformer calculated here where 
the Ga does not involve coordination to the phosphate group of the dipeptide ligand.  In this 
structure the Ga is bound to three carbonyl oxygen atoms of the LysNTA substrate and a 
carbonyl oxygen atom of the valine residue.  Structure 2B is calculated to be 17.1 kcal mol-1 
higher in free energy relative to structure 2A indicating a preference for Ga binding to the 
phosphate group. The inference here (which would take a much larger study to verify) is that 
Ga tagging complexes, such as the one described here, can successfully target the phosphate 
group, but that the stability of the complex will also depend on the residue sequence of the 
peptide.  It is also possible that weaker complexes could form with peptides that do not 
contain phosphate. This was investigated by comparing the enthalpies of two reactions, the 
first being the reaction between the Ga-LysNTA substrate and phosphopeptide PDGF β-
receptor to produce the complex Ga-LysNTA-β-PDGF, structure 2A as shown in Figure 8, 
while the second is the equivalent reaction between the Ga-LysNTA substrate and same 
dipeptide where the phosphate group was removed and replaced with a phenolic OH group. 
The enthalpies for these reactions at 298 K were calculated to be -113.7 and -51.5 kcal mol-1 
respectively; indicating weaker complex formation in the absence of the phosphate group and 
at the same time a strong preference for the Ga binding to the phosphate group.  This would 
be revealed by an increased complexity in the elemental chromatogram, but could be 
controlled by varying the experimental conditions or chemical blocking of competing groups.  
A group of five internal hydrogen bonds help not only to stabilize Structure 2A but also 
results in a somewhat constricted configuration.  Although we expect 6 coordination for Ga, 
efforts to obtain structures with higher coordination at the gallium centre were not successful; 
in fact, only one structure of the other five conformers calculated for this complex exhibited 
gallium penta-coordination whereas others involved either tri- or tetra-coordinated gallium 
metal and were shown (see HF data listed in Table S1) not to be very energetically 
competitive. This is most likely due to steric crowding given the bulky ligands that are 
surrounding the Ga.  Finally, a two layer ONIOM method was used to model Structure 2A 
shown in Figure 8, predominantly in order to determine the feasibility of this method for 
examining larger transition metal containing complexes to be investigated in future works.   
The selection of the high layer, modelled at B3LYP/LANL2DZ, included the active portion 
of the system the gallium centre and its coordinating sites, the phosphate group as well as all 
atoms involved in hydrogen bonding, the remainder of the complex on the other hand was 
treated using semi-empirical techniques employing the PM6 method.  Of major interest are 
the ONIOM obtained geometries which were shown in Figure 8 to be very similar to those 
resulting from the B3LYP/LANL2DZ calculations.  This provides us with good indications 
that such two layered calculations may be used in the future to obtain relative energies of 
different conformers of larger transition metal-containing complexes provided that adequate 
care is taken to include exactly the same numbers and types of atoms in the high layer in each 
of the conformers examined.     
Conclusions 
This work demonstrates that Ga-LysNTA can be used to tag the phosphate moiety in a model 
phosphopeptide thereby enabling the detection of the peptide through the Ga atom by ICP-
MS.  LC-ICP-MS data showed the co-elution of the 31P of the phosphorylated peptide and the 
69Ga of the label, indicating successful Ga-LysNTA-β-PDGF formation. Unambiguous 
identification of the labelled complex was achieved through ESI-MSn and accurate mass FT-
MS data. Excellent correlation with the theoretically predicted spectra were shown (see 
Figure 5). Molecular modelling supported the MS data and revealed that just one of the 
phosphate oxygen atoms was targeted by the Ga centre, the other analyte derived 
coordination sites being provided by electron donating groups on the amino acid residues. 
This suggests that complex stability will vary from peptide to peptide and may go some way 
to explaining why there are diverse and sometimes contradictory reports in the literature 
regarding the efficiency and selectivity of metal affinity techniques. 
 
Future work will aim to investigate further the issue of selectivity using different peptide 
sequences and tryptic digests of phosphopetides.  The ultimate aim is to quantify 
phosphopeptides by elemental mass spectrometry using isotope dilution analysis with spiked 
gallium.  
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Figure and Table Captions 
Figure 1: Signal due to Ga-LysNTA tag from LTQ Ion Trap MS; Panel A experimental data, 
Panel B theoretically predicted spectra at a resolving power of 1500 m/Δm.  
Figure 2: Structures for the Ga-LysNTA singly charged positive ions as calculated at the 
HF/STO3G and B3LYP/LANL2DZ (italicized numbers) levels of theory.  Bond lengths are 
in Angstroms, relative free energies are indicated in parenthesis.   
Figure 3: Formation of [Ga-LysNTA.H2O ]+ from Q-Exactive FTMS; Panel A experimental 
data, Panel B theoretically predicted spectra. 
Figure 4: Panel A experimental signal due to [Ga-LysNTA]+  adducts with H2O and CH3OH 
from LTQ Ion Trap MS, Panel B theoretically predicted composite spectrum of a 1:2 ratio of 
[Ga-LysNTA.2H2O]+ and [Ga-LysNTA.CH3OH]+ at a resolving power of 1000 m/Δm.  
Figure 5: Full scan spectra of reaction mixture from LTQ Ion Trap MS showing evidence of 
[Ga-LysNTAPDGF]+ formation (main figure, insert A experimental data, insert B 
theoretically predicted spectra of [Ga-LysNTAPDGF]+) at a resolving power of 1700 m/Δm. 
Figure 6: Product ion scan of [Ga-LysNTAPDGF]+  at m/z 1030 from LTQ Ion Trap MS. 
 
Figure 7: LC-ICP-MS chromatogram of [Ga-LysNTAPDGF]+ from Element 2XR; panel A 
signal from 31P, panel B signal from 69Ga. 
Figure 8: the lowest energy structure 2A calculated for the Ga-LysNTA-β-PDGF singly 
charged positive ions as calculated using the ONIOM method at B3LYP/LANL2DZ:PM6 
and the B3LYP/LANL2DZ (italicized numbers) levels of theory.  Bond lengths are in 
Angstroms, relative free energies are indicated in parenthesis.   
 
 
Table 1: Summary of the mass accuracy for all proposed assignments of Ga-LysNTA with 
methanol and water adducts and PDGF. 
Supplementary Material 
 
Table S1: Electronic energies, Zero-Point Vibrational Energies, Thermal Energies, Entropies 
and relative free energies for species calculated at HF/STO3G and B3LYP/LANL2DZ 
(italicized values). ONIOM values for species 2A are listed in bold within and underneath the 
table. 
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Figure 1: Signal due to Ga-LysNTA tag from LTQ Ion Trap MS; Panel A experimental data, 
Panel B theoretically predicted spectrum at a resolving power of 1500 m/Δm.  
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Figure 2: Structures for the Ga-LysNTAsingly charged positive ions as calculated at the 
HF/STO3G and B3LYP/LANL2DZ (italicized numbers) levels of theory.  Bond lengths are 
in Angstroms, relative free energies (in kcal per mol) are indicated in parenthesis.   
 
 Figure 3: Formation of [Ga-LysNTA.H2O ]+ from Q-Exactive FTMS; Panel A experimental 
data, Panel B theoretically predicted spectra. 
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Figure 4: Panel A experimental signal due to [Ga-LysNTA]+  adducts with H2O and CH3OH 
from LTQ Ion Trap MS, Panel B theoretically predicted composite spectrum of a 1:2 ratio of 
[Ga-LysNTA.2H2O]+ and [Ga-LysNTA.CH3OH]+at a resolving power of 1000 m/Δm.  
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 Figure 5: Full scan spectra of reaction mixture from LTQ Ion Trap MS showing evidence of 
[Ga-LysNTAPDGF]+ formation (main figure, insert A experimental data, insert B 
theoretically predicted spectra) at a resolving power of 1700 m/Δm. 
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Figure 6: Product ion scan of [Ga-LysNTAPDGF]+  at m/z 1030 from LTQ Ion Trap MS. 
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Figure 7: LC-ICP-MS chromatogram of [Ga-LysNTAPDGF]+ from Element 2XR;Panel A 
signal from 31P, Panel B signal from 69Ga. 
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Figure 8: the lowest energy structure 2A calculated for the Ga-LysNTA-β-PDGF singly 
charged positive ions as calculated using the ONIOM method at B3LYP/LANL2DZ:PM6 
and the B3LYP/LANL2DZ (italicized numbers) levels of theory.  Bond lengths are in 
Angstroms, relative free energies are indicated in parenthesis.   
 
 
Table S1: Electronic energies, Zero-Point Vibrational Energies, Thermal Energies, Entropies and 
relative free energies for species calculated at HF/STO3G and B3LYP/LANL2DZ (italicized values). 
ONIOM values for species 2A are listed in bold within and underneath the table. 
 
Structure 
Electronic 
energy 
(Hartrees) 
ZPE 
(kcal mol-1) 
????? ? ??? 
(kcal mol-1) 
Entropy 
(cal mol-1 K-1) 
Relative free 
energy at 298 K 
(kcal mol-1) 
1A -2834.8816135 204.4 10.8 130.3 0.0 
 
 
1B 
 
 
1C 
 
 
1D 
-953.3907574 
 
-2834.8678164 
-953.3728666 
 
-2834.8555209 
-953.3229606 
 
-2834.8480638 
175.7 
 
204.6 
175.0 
 
203.2 
172.5 
 
203.1 
12.2 
 
11.6 
12.4 
 
11.9 
13.1 
 
12.0 
141.1 
 
136.5 
142.3 
 
141.9 
149.7 
 
142.4 
0.0 
 
7.8 
10.3 
 
12.8 
37.6 
 
17.4 
 
 
1E 
 
 
1F 
 
 
1G 
 
 
1H 
 
 
2A 
 
 
 
2B 
 
2C 
 
2D 
 
2E 
 
2F 
-953.3104025 
 
-2834.8099823 
-953.2955212 
 
-2834.7960201 
--- 
 
-2834.7911950 
--- 
 
-2834.6674103 
--- 
 
-5722.4171784 
-3167.9951469 
-1334.8454825 
 
-5722.3869160 
 
-5722.3712784 
 
-5722.3510408 
 
-5722.1362298 
 
-5722.1339100 
 
171.9 
 
204.8 
174.3 
 
202.4 
-- 
 
204.7 
-- 
 
201.4 
-- 
 
787.1 
673.6 
624.0 
 
785.7 
 
786.0 
 
785.5 
 
786.4 
 
785.8 
13.3 
 
11.5 
12.4 
 
12.3 
-- 
 
11.1 
-- 
 
12.6 
-- 
 
42.6 
45.6 
47.2 
 
42.8 
 
43.1 
 
43.2 
 
43.8 
 
44.7 
150.6 
 
136.0 
140.7 
 
145.2 
-- 
 
131.8 
-- 
 
150.0 
-- 
 
376.7 
390.7 
408.8 
 
378.6 
 
380.1 
 
384.8 
 
399.2 
 
424.2 
44.7 
 
44.4 
58.6 
 
48.8 
-- 
 
57.0 
-- 
 
127.3 
-- 
 
0.0 
-- 
-- 
 
17.1 
 
21.7 
 
38.0 
 
170.0 
 
164.3 
 
ONIOM: PM6 model system energy: -0.612107102528 
ONIOM: B3LYP/LANL2DZ model system energy: -1334.375450261843 
ONIOM: PM6 real system energy: -1.082139387972 
ONIOM: extrapolated energy: -1334.845482547287 
  
 Table 1: Summary of the mass accuracy for all proposed assignments of LysNTAGa  
with methanol and water adducts and PDGF. 
Ion or cluster (m/z) Experimental m/z Theoretical m/z Mass 
Accuracy 
(ppm) 
329.0259 329.0259 
330.0292 
331.0250 
332.0284 
329.0259 
330.0292 
331.0250 
332.0283 
0.0 
0.0 
0.0 
0.3 
347.0364 347.0364 
348.0398 
349.0355 
350.0389 
347.0364 
348.0398 
349.0356 
350.0389 
0.0 
0.0 
-0.3 
0.0 
361.0520 361.0520 
362.0554 
363.0513 
364.0556 
361.0521 
362.0554 
363.0512 
364.0546 
-0.3 
0.0 
0.3 
2.7 
1030.3118 1030.3118 
1031.3152 
1032.3109 
1033.3143 
1030.3109 
1031.3118 
1032.3196 
1033.3105 
0.9 
3.3 
-8.4 
3.7 
 
 
 
